Meeting the robust demand for life science products and solutions in China's western market
Delivering faster shipments and more convenient customer service and solutions
Strengthening our commitment to China's scientific community
Global technology leader Merck announced on May 22 the official launch of its distribution center in Chengdu, Sichuan. This marks Merck's enhanced logistics capabilities in China's life sciences sector and improved customer experience.Merck will deliver biochemical reagents and laboratory analytical reagents more swiftly to customers in western China, supporting scientific research.
As a technology company with over 350 years of history yet still vibrant, Merck remains driven by curiosity, passionate about exploring technological innovation, and committed to providing global life science users with a high-quality product portfolio and innovative capabilities.
"China holds significant strategic importance for Merck's global sustainable growth. We are committed to providing high-quality product portfolios and innovation capabilities to life science users worldwide, while consistently valuing our commitment to China. The official operation of the Chengdu Distribution Center represents a major initiative to enhance customer service levels in western China. Amid evolving policy and industry environments, we will continuously explore innovative and effective ways to strengthen service levels and user experience for our Chinese customers,"Mr. Steve Vermant, Managing Director of Merck Life Sciences China, stated.
To ensure high-quality product delivery, the Chengdu Distribution Center is equipped with diverse storage facilities meeting various temperature-controlled requirements, including multi-temperature zones such as constant temperature, cool, refrigerated, and frozen storage.The first batch of products delivered to customers includes laboratory analytical reagents and consumables for testing in pharmaceutical, food, environmental, and research laboratories. It also features high-performance materials reagents for research and industrial applications, along with foundational reagents for broader use across research, biotechnology, pharmaceuticals, diagnostics, and industrial sectors. Additional products will be added to the inventory in the near future.
As a global life sciences company, Merck consistently supports rapid industry growth by providing leading innovative solutions to its Chinese customers and partners, continuing to drive the dynamic biotechnology market in Asia.
About Merck
Merck is a leading science and technology company focused on three key areas: healthcare, life sciences, and high-performance materials.Approximately 57,000 employees worldwide work at Merck, driving technological progress and improving people's lives through innovations ranging from biologics for cancer and multiple sclerosis to cutting-edge systems for scientific research and production, as well as liquid crystal materials for smartphones and flat-screen televisions. In 2019, Merck achieved total sales of €16.2 billion in 66 countries.Scientific exploration and responsible entrepreneurship have always been key to Merck's technological progress and the secret to its enduring vitality since 1668.The Merck family, as the company's founders, still holds the majority of Merck shares. Globally, we are known as "Merck," with the exception of the United States and Canada. In these two countries, Merck's three major divisions—Healthcare, Life Science, and Performance Materials—are respectively known as "EMD Serono," "MilliporeSigma," and "EMD Performance Materials."